Dr. Reddy’s introduces new logo, brand identity
G.V. Prasad, Co-chairman& CEO of Dr. Reddy's, at an event at the company's North American headquarters in Princeton, N.J. on Wednesday.
HYDERABAD, India — Dr. Reddy’s on Wednesday announced a rebranding, with a new logo meant to give the company a new, more visual identity.
The new purple logo is meant to express the dynamism, creativity and empathy — three values at the heart of its commitment to patients, Dr. Reddy's noted in a statement.
The rebranding, which will unify the brand and display the company’s willingness to meet new challenges, will extend to all Dr. Reddy’s product packaging once the legal processes and documentation necessary is complete. For the company, it is aimed at putting a fresh look on its five core principles: bringing expensive medicines within reach of patients who need them; addressing unmet patient needs; helping patients manage their disease better, working with partners to help them succeed and enabling product availability at pharmacy.
“Over 31 years, Dr. Reddy’s has grown from a manufacturer of APIs into a multinational pharmaceutical brand of repute, with operations in over 25 countries,” Dr. Reddy’s Chairman Satish Reddy said. “Throughout this journey, we have remained true to our core values, even as we continually transform to keep pace with the changing needs of our patients and partners. Our belief ‘Good Health Can’t Wait’ lends new meaning to our core purpose of accelerating access to affordable and innovative medicines.”
Teva launches generic Aggrenox in United States
JERUSALEM — Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.
“Teva recognizes the devastating impact of a stroke and is pleased to launch generic aspirin and extended-release dipyridamole capsules as a treatment option for at-risk stroke patients,” Brendan O’Grady, Teva’s president and CEO of North America Generic Medicines, said.
The National Institutes of Health estimates 185,000 Americans are at risk of another stroke within five years of a previous stroke. Every year, more than 795,000 Americans have a stroke, and 25% have had a previous stroke.
APhA seeks candidates for 2016 election cycle
WASHINGTON, D.C. — The American Pharmacists Association has issued a call for candidates in the 2016 APhA election cycle. It requests applicants for the APhA Board of Trustees, APhA-Academy of Pharmacy Practice and Management and APhA-Academy of Pharmaceutical Research and Science.
One position is open for the office of the president-elect and two positions are open for the board of trustees.
Three member-at-large positions are open in the APhA-APPM Executive Committee, in addition to the new practitioner officer position.
APhA-APRS seeks candidates for APhA-APRS president-elect, postgraduate officer and chair-elect for the academy’s basic sciences, clinical sciences and ESAS divisions.
Candidates must submit the online application by Oct. 1 and attach the following items in the application:
- High resolution headshot, suitable for publication
- CV or resume
The 2016 election timeline is as follows:
Oct. 1, 2015: Application deadline for 2016 APhA election cycle
Nov. – Dec. 2015: Nomination Committee meets, election slate announced
March 4, 2016 – May 2, 2016: Voting period for 2016 elections
June 2016: APhA 2016 election results announced
March 24 – 27, 2017: Successfully elected candidates are installed at APhA2017 in San Francisco